Increased apoptosis induction by 121F mutant p53

Area of Science:

• Molecular Biology
• Cancer Research
• Genetics

Background:

• Mutations in the p53 tumor suppressor gene are common in cancers, typically leading to reduced DNA binding and apoptosis induction.
• Understanding p53 mutant phenotypes is crucial for developing targeted cancer therapies.

Purpose of the Study:

• To characterize a novel p53 mutant (121F) with enhanced apoptosis-inducing capabilities.
• To investigate the mechanisms underlying the increased apoptotic function and altered sequence specificity of the 121F mutant.
• To identify new p53 target genes involved in apoptosis.

Main Methods:

• Characterization of p53 mutant binding affinity and apoptosis induction.
• Analysis of MDM2 transcription activation and feedback regulation.
• DNA chip screening of RNA from cells expressing p53 mutants (121F and 277R).

Main Results:

• The 121F p53 mutant exhibits increased DNA binding affinity and apoptosis induction compared to wild-type p53.
• 121F selectively fails to activate MDM2 transcription, leading to its overexpression and enhanced apoptotic function.
• Two novel apoptosis mediators, Rad and PIR121, were identified as being better induced by 121F than wild-type p53.
• The 121F mutant demonstrates tumor cell killing irrespective of p53 status.

Conclusions:

• The 121F p53 mutant's potent apoptosis-inducing phenotype results from decreased MDM2 feedback and enhanced expression of specific target genes.
• The identification of Rad and PIR121 provides new insights into p53-mediated apoptosis pathways.
• The 121F mutant holds promise for expanding the scope of p53 gene therapy in various tumor types.